Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Burkholderia mallei
Calendula
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 11; 28(6):600-606.
View in:
PubMed
subject areas
Administration, Oral
Anemia
Erythropoiesis
Erythropoietin
Humans
Hypoxia-Inducible Factor-Proline Dioxygenases
Intracellular Signaling Peptides and Proteins
Kidney Failure, Chronic
Mitochondrial Proteins
Prolyl-Hydroxylase Inhibitors
Renal Insufficiency, Chronic
authors with profiles
Ajaypal Singh